Benefits of the use of tranexamic acid in the treatment of Melasma
DOI:
https://doi.org/10.33448/rsd-v10i16.24104Keywords:
Melasma; Hyperchromia; Tranexamic Acid.Abstract
The skin hyperchromias are frequent sequels due to some disorder in the physiological process of people, among them, hormonal changes, inflammation, allergies, aging, excessive sun exposure. The process of tissue hyperpigmentation occurs due to the increased production of melanin by cells called melanocytes. Melasma is a hyperchromia that affects photo exposed areas of the body, especially the face of women in fertile age, generating an unwanted unaesthetic aspect that directly affects self-esteem. Tranexamic acid has been shown to be an efficient depigmenting agent to lighten people's skin, consequently improving their quality of life. This is an integrative literature review, using as a source of data existing scientific articles in the online platform. Searches were made using the descriptors: melasma, tranexamic acid, hyperpigmentation, in electronic databases, which address the subject of this study: Experimental research that comprove the effectiveness of ATX active in its pure concentration, and with bleaching combinations, through the injectable methods, orally and microagulation, providing the reduction of pigmentary dyschromias, and may improve the results and quality of life of people. Although there are few studies and volunteers about the theme. It is concluded that tranexamic acid is an antiangiogenic active and with potential whitening action that can be administered topically, orally and injected, besides being considered safe. Furthermore, we emphasize the importance of further research related to the topic that can contribute to the creation of safe protocols with the use of the substance by professionals.
References
Miot, L. D. B., Miot, H. A., Silva, M. G. D., & Marques, M. E. A. (2009). Physiopathology of melasma. Anais brasileiros de dermatologia, 84, 623-635.
Nicolaidou, E., & Katsambas, A. D. (2014). Pigmentation disorders: hyperpigmentation and hypopigmentation. Clinics in dermatology, 32(1), 66-72.
Gonchoroski, D. D., & Corrêa, G. M. (2005). Tratamento de hipercromia pós-inflamatória com diferentes formulações clareadoras. Infarma, 17(3-4), 84-8.
Miot, L. D. B., Miot, H. A., Silva, M. G. D., & Marques, M. E. A. (2009). Fisiopatologia do melasma. Anais brasileiros de dermatologia, 84, 623-635.
Barbosa, K. L., & Guedes, M. R. M. (2018). Melasma: tratamento e suas implicações estéticas. Infarma-Ciências Farmacêuticas, 30(2), 85-94.
Padhi, T., & Pradhan, S. (2015). Oral tranexamic acid with fluocinolone-based triple combination cream versus fluocinolone-based triple combination cream alone in melasma: an open labeled randomized comparative trial. Indian Journal of Dermatology, 60(5), 520.
Nasrollahi, S. A., Nematzadeh, M. S., Samadi, A., Ayatollahi, A., Yadangi, S., Abels, C., & Firooz, A. (2019). Evaluation of the safety and efficacy of a triple combination cream (hydroquinone, tretinoin, and fluocinolone) for treatment of melasma in Middle Eastern skin. Clinical, cosmetic and investigational dermatology, 12, 437.
Rescaroli¹, A. C., da Silva, G. M., & Valdameri, G. A. (2009). Foliculite e a depilação: seqüelas, tratamentos e o papel do Tecnólogo em Cosmetologia e Estética. Monografia] Balneário Camboriú: Universidade do Vale do Itajaí–UNIVALI.
Alves-Mazzotti, A. J. (2002). Repensando algumas questões sobre o trabalho infanto-juvenil. Revista Brasileira de Educação, 87-98.
Witt, A. S., & da Silva, F. C. C. (2021). Living Labs nas Universidades Federais do Brasil. Fórum de Estudos em Informação, Sociedade e Ciência, 4, 146-154.
Kontze, P. R., & Bianchetti, P. (2018). Eficácia do ácido tranexâmico no tratamento do melasma. Revista Destaques Acadêmicos, 10(3).
Costa, A. F., Melo, D. M. A., Melo, M. A. F., Medeiros, R. L. B. A., Pimentel, P. M., Câmara, M. S. C., & Chantelle, L. (2016). Preparação de pigmentos de aluminatos de cobalto para aplicação em vidrados cerâmicos. Cerâmica, 62, 179-185.
Steiner, D., Feola, C., Bialeski, N., de Morais, F. A., Antiori, A. C. P., Addor, F. A. S. A., & Folino, B. B. (2009). Estudo de avaliação da eficácia do ácido tranexâmico tópico e injetável no tratamento do melasma. Surgical & Cosmetic Dermatology, 1(4), 174-177.
Steiner, D., Feola, C., Bialeski, N., & de Morais, F. A. (2009). Tratamento do melasma: revisão sistemática. Surgical & Cosmetic Dermatology, 1(2), 87-94.
Kim, E. H., Kim, Y. C., Lee, E. S., & Kang, H. Y. (2007). The vascular characteristics of melasma. Journal of dermatological science, 46(2), 111-116.
Maeda, K., & Naganuma, M. (1998). Topical trans-4-aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation-induced pigmentation. Journal of Photochemistry and Photobiology B: Biology, 47(2-3), 136-141.
Spadafora, Maria Claudia Fonseca de Almeida et al. Os benefícios dos despigmentantes para o tratamento do melasma e rejuvenescimento facial. Revista 34 Saúde em Foco, n. 11, 2019
Cassiano, D. P. (2021). Estudo clínico sobre eficácia, segurança e mecanismos de ação do microagulhamento e ácido tranexâmico oral no tratamento do melasma facial.
Silva, S. D. N. (2018). Microagulhamento com uso de ácido tranexamico para o tratamento de melasma. CCE cursos.
Lopes, D. d. S., & Silva, A. C. C. d. (2017). A utilização do ácido tranexâmico no tratamento de melasma. Revista Científica da FHO, 5(1).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Larissa Almeida Silva; Maria Antonia Santos Silva; Jeane Rocha Santos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
